Literature DB >> 18297329

Spinocerebellar ataxia type 2 (SCA2) in an Egyptian family presenting with polyphagia and marked CAG expansion in infancy.

Alice Abdel-Aleem1, Maha S Zaki.   

Abstract

We describe an Egyptian family having SCA2 affecting three generations with marked molecular and clinical anticipation observed in the index case. Our proband was a male child starting as early as 2 years old with progressive extrapyramidal manifestations, slow eye movements and cognitive impairment. A history of nonspecific mild developmental delay was recorded. The patient lost all cognitive functions, had persistent dystonic posture, trophic changes, vasomotor instability, dysphagia and died at the age of 7 years. The age at presentation among other affected family members varied between 11 and 45 years old across three generations. The early common neurological symptoms were choreoathetotic movements, myoclonic jerk, gait difficulty, expressionless face and emotional liability. Later, overt ataxia, incoordination, dysarthria, mild dementia and slow eye saccades predominated. Brisk tendon reflexes were detected in three cases. Peripheral nerve affection was a late manifestation. Interestingly, polyphagia and obesity were striking manifestations in the middle stage of the disease; an observation that might support a previously suggested relation between the ataxin-2 gene and body weight. The proband showed an amplified allele with marked CAG expansion in the form of a smear sized 69-75 repeats resulted from maternal transmission. To our knowledge, our index case is the second report in the literature presenting with infantile onset SCA2 and intermediate repeat expansion. This family expands the phenotypic spectrum of early onset SCA2 and points out the importance of considering SCA2 gene analysis in children with progressive neurological impairment and abnormal movements with or without polyphagia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18297329     DOI: 10.1007/s00415-008-0690-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  20 in total

1.  The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia.

Authors:  D H Geschwind; S Perlman; C P Figueroa; L J Treiman; S M Pulst
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

2.  SCA2 trinucleotide expansion in German SCA patients.

Authors:  O Riess; F A Laccone; S Gispert; L Schöls; C Zühlke; A M Vieira-Saecker; S Herlt; K Wessel; J T Epplen; B H Weber; F Kreuz; S Chahrokh-Zadeh; A Meindl; A Lunkes; J Aguiar; M Macek; A Krebsová; M Macek; K Bürk; S Tinschert; I Schreyer; S M Pulst; G Auburger
Journal:  Neurogenetics       Date:  1997-05       Impact factor: 2.660

3.  Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families.

Authors:  G Cancel; A Dürr; O Didierjean; G Imbert; K Bürk; A Lezin; S Belal; A Benomar; M Abada-Bendib; C Vial; J Guimarães; H Chneiweiss; G Stevanin; G Yvert; N Abbas; F Saudou; A S Lebre; M Yahyaoui; F Hentati; J C Vernant; T Klockgether; J L Mandel; Y Agid; A Brice
Journal:  Hum Mol Genet       Date:  1997-05       Impact factor: 6.150

4.  Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.

Authors:  B Tang; C Liu; L Shen; H Dai; Q Pan; L Jing; S Ouyang; J Xia
Journal:  Arch Neurol       Date:  2000-04

5.  CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1.

Authors:  Y Kawaguchi; T Okamoto; M Taniwaki; M Aizawa; M Inoue; S Katayama; H Kawakami; S Nakamura; M Nishimura; I Akiguchi
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

6.  A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes.

Authors:  J P Warner; L H Barron; D J Brock
Journal:  Mol Cell Probes       Date:  1993-06       Impact factor: 2.365

7.  Childhood-onset ataxia: testing for large CAG-repeats in SCA2 and SCA7.

Authors:  Rong Mao; Arthur S Aylsworth; Nicholas Potter; William G Wilson; Galen Breningstall; Myra J Wick; Dusica Babovic-Vuksanovic; Martha Nance; Marc C Patterson; Christopher M Gomez; Karen Snow
Journal:  Am J Med Genet       Date:  2002-07-15

8.  Phenotype variation correlates with CAG repeat length in SCA2--a study of 28 Japanese patients.

Authors:  H Sasaki; A Wakisaka; K Sanpei; H Takano; S Igarashi; T Ikeuchi; K Iwabuchi; T Fukazawa; T Hamada; T Yuasa; S Tsuji; K Tashiro
Journal:  J Neurol Sci       Date:  1998-08-14       Impact factor: 3.181

9.  Spinocerebellar ataxia type 2 (SCA 2) in an infant with extreme CAG repeat expansion.

Authors:  D Babovic-Vuksanovic; K Snow; M C Patterson; V V Michels
Journal:  Am J Med Genet       Date:  1998-10-12

10.  Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA).

Authors:  R Koide; T Ikeuchi; O Onodera; H Tanaka; S Igarashi; K Endo; H Takahashi; R Kondo; A Ishikawa; T Hayashi
Journal:  Nat Genet       Date:  1994-01       Impact factor: 38.330

View more
  13 in total

1.  Selective Forces Related to Spinocerebellar Ataxia Type 2.

Authors:  Lucas Schenatto Sena; Raphael Machado Castilhos; Eduardo Preusser Mattos; Gabriel Vasata Furtado; José Luiz Pedroso; Orlando Barsottini; Maria Marla Paiva de Amorim; Clecio Godeiro; Maria Luiza Saraiva Pereira; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2019-04       Impact factor: 3.847

2.  Massive expansion of SCA2 with autonomic dysfunction, retinitis pigmentosa, and infantile spasms.

Authors:  A R Paciorkowski; Y Shafrir; J Hrivnak; M C Patterson; M B Tennison; H B Clark; C M Gomez
Journal:  Neurology       Date:  2011-08-31       Impact factor: 9.910

3.  Jaw-Opening Oromandibular Dystonia Associated With Spinocerebellar Ataxia Type 2.

Authors:  Antonella Antenora; Silvio Peluso; Francesco Saccà; Giuseppe De Michele; Alessandro Filla
Journal:  Mov Disord Clin Pract       Date:  2014-05-26

4.  Clinical and genetic analysis of spinocerebellar ataxia in Mali.

Authors:  M Traoré; T Coulibaly; K G Meilleur; A La Pean; M Sangaré; G Landouré; F Mochel; M Karambé; C O Guinto; K H Fischbeck
Journal:  Eur J Neurol       Date:  2011-03-21       Impact factor: 6.089

Review 5.  Spinocerebellar ataxia type 2: clinical presentation, molecular mechanisms, and therapeutic perspectives.

Authors:  J J Magaña; L Velázquez-Pérez; B Cisneros
Journal:  Mol Neurobiol       Date:  2012-09-21       Impact factor: 5.590

6.  Infantile childhood onset of spinocerebellar ataxia type 2.

Authors:  Roberto Di Fabio; Filippo Santorelli; Enrico Bertini; Martina Balestri; Laura Cursi; Alessandra Tessa; Francesco Pierelli; Carlo Casali
Journal:  Cerebellum       Date:  2012-06       Impact factor: 3.847

Review 7.  12q24 locus association with type 1 diabetes: SH2B3 or ATXN2?

Authors:  Georg Auburger; Suzana Gispert; Suna Lahut; Ozgür Omür; Ewa Damrath; Melanie Heck; Nazlı Başak
Journal:  World J Diabetes       Date:  2014-06-15

8.  Evaluation of A2BP1 as an obesity gene.

Authors:  Lijun Ma; Robert L Hanson; Michael T Traurig; Yunhua L Muller; Bakhshish P Kaur; Jessica M Perez; David Meyre; Mao Fu; Antje Körner; Paul W Franks; Wieland Kiess; Sayuko Kobes; William C Knowler; Peter Kovacs; Philippe Froguel; Alan R Shuldiner; Clifton Bogardus; Leslie J Baier
Journal:  Diabetes       Date:  2010-08-19       Impact factor: 9.461

9.  Two young sisters with spinocerebellar ataxia type 2 showing different clinical progression of disease.

Authors:  Uluç Yiş; Eray Dirik; Semra Hiz Kurul; Asli Gündoğdu Eken; A Nazli Başak
Journal:  Cerebellum       Date:  2008-11-21       Impact factor: 3.847

Review 10.  Myoclonus-Ataxia Syndromes: A Diagnostic Approach.

Authors:  Malco Rossi; Sterre van der Veen; Marcelo Merello; Marina A J Tijssen; Bart van de Warrenburg
Journal:  Mov Disord Clin Pract       Date:  2020-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.